Aldava, Churchi, JR. A.
HRN: 19-64-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/27/2023
09/03/2023
IVTT
72mg
Q6hrs
Foreign Body Ingestion
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes